Cargando…
Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma
PURPOSE: We investigated the effect of carbonic anhydrase IX (CA IX) inhibitor under hypoxia and normoxia in SaOS2 human osteosarcoma cell line. We also evaluated the expression of CA IX in 27 patients diagnosed with osteosarcoma. MATERIALS AND METHODS: CA IX expression in SaOS2 cells cultured under...
Autores principales: | Okuno, Kazuma, Matsubara, Takao, Nakamura, Tomoki, Iino, Takahiro, Kakimoto, Takuya, Asanuma, Kunihiro, Matsumine, Akihiko, Sudo, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190629/ https://www.ncbi.nlm.nih.gov/pubmed/30349321 http://dx.doi.org/10.2147/OTT.S177605 |
Ejemplares similares
-
STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma
por: Oi, Toru, et al.
Publicado: (2016) -
The clinical outcomes of total femur prosthesis in patients with musculoskeletal tumors
por: Kakimoto, Takuya, et al.
Publicado: (2019) -
Treatment of the benign bone tumors including femoral neck lesion using compression hip screw and synthetic bone graft
por: Nakamura, Tomoki, et al.
Publicado: (2015) -
The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas
por: Hagi, Tomohito, et al.
Publicado: (2017) -
Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung
por: Nakamura, Tomoki, et al.
Publicado: (2017)